Aspiriant, LLC Abb Vie Inc. Transaction History

Aspiriant, LLC

$2.61 Billion
Q3 2024

A detailed history of Aspiriant, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aspiriant, LLC holds 8,365 shares of ABBV stock, worth $1.49 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,365

Previous 8,498 1.57%

Holding current value

$1.49 Million

Previous $1.46 Million 13.32%

% of portfolio

0.06%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$163.84 - $199.33 $21,790 - $26,510	-133 Reduced 1.57%	8,365 $1.65 Million
Q2 2024 Jul 15, 2024	SELL	$154.79 - $180.76 $118,723 - $138,642	-767 Reduced 8.28%	8,498 $1.46 Million
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $41,553 - $47,346	260 Added 2.89%	9,265 $1.69 Million
Q4 2023 Jan 26, 2024	SELL	$137.6 - $154.97 $29,721 - $33,473	-216 Reduced 2.34%	9,005 $1.4 Million
Q3 2023 Oct 17, 2023	SELL	$133.59 - $154.65 $3,473 - $4,020	-26 Reduced 0.28%	9,221 $1.37 Million
Q2 2023 Jul 19, 2023	BUY	$132.51 - $164.9 $50,221 - $62,497	379 Added 4.27%	9,247 $1.25 Million
Q1 2023 Apr 27, 2023	BUY	$144.61 - $166.54 $55,530 - $63,951	384 Added 4.53%	8,868 $1.41 Million
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $69,431 - $83,266	502 Added 6.29%	8,484 $0
Q3 2022 Oct 28, 2022	SELL	$134.21 - $153.93 $1.16 Million - $1.33 Million	-8,632 Reduced 51.96%	7,982 $1.07 Million
Q2 2022 Jul 25, 2022	BUY	$137.62 - $174.96 $7,569 - $9,622	55 Added 0.33%	16,614 $2.54 Million
Q1 2022 May 06, 2022	BUY	$131.98 - $163.75 $1.19 Million - $1.47 Million	8,999 Added 119.03%	16,559 $2.68 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $24,386 - $30,856	227 Added 3.1%	7,560 $1.02 Million
Q3 2021 Oct 27, 2021	SELL	$106.4 - $120.78 $638 - $724	-6 Reduced 0.08%	7,333 $791,000
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $7,785 - $8,673	-74 Reduced 1.0%	7,339 $827,000
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $78,566 - $86,492	768 Added 11.56%	7,413 $801,000
Q4 2020 Feb 01, 2021	BUY	$80.49 - $108.67 $13,602 - $18,365	169 Added 2.61%	6,645 $710,000
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $429 - $504	-5 Reduced 0.08%	6,476 $566,000
Q2 2020 Aug 06, 2020	SELL	$73.37 - $98.18 $5,429 - $7,265	-74 Reduced 1.13%	6,481 $636,000
Q1 2020 May 05, 2020	BUY	$64.5 - $97.79 $75,852 - $115,001	1,176 Added 21.86%	6,555 $499,000
Q4 2019 Jan 27, 2020	SELL	$72.13 - $90.25 $19,042 - $23,826	-264 Reduced 4.68%	5,379 $475,000
Q3 2019 Nov 04, 2019	BUY	$62.98 - $75.72 $124,070 - $149,168	1,970 Added 53.63%	5,643 $428,000
Q1 2019 May 03, 2019	SELL	$77.14 - $90.79 $153,354 - $180,490	-1,988 Reduced 35.12%	3,673 $295,000
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $13,468 - $16,609	-173 Reduced 2.97%	5,661 $521,000
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $57,880 - $64,344	-651 Reduced 10.04%	5,834 $552,000
Q2 2018 Aug 07, 2018	BUY	$89.78 - $106.23 $4,040 - $4,780	45 Added 0.7%	6,485 $601,000
Q1 2018 May 04, 2018	BUY	$92.01 - $123.21 $592,544 - $793,472	6,440 New	6,440 $610,000
Q4 2017 Jan 31, 2018	SELL	$89.56 - $98.21 $381,704 - $418,571	-4,262 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $297,700 - $380,255	4,262	4,262 $379,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $315B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspiriant, LLC with notifications on news.

Account